[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 48, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 1063506, "exercisedValue": 0, "unexercisedValue": 81300}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 68, "title": "Chief Legal Officer, Chief Compliance Officer &Secretary", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 713215, "exercisedValue": 0, "unexercisedValue": 40200}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 45, "title": "Chief Operating Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Wargacki Ph.D.", "age": 46, "title": "Chief Science Officer", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "title": "Senior Vice President of Sales & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 58, "title": "Senior Vice President of Information Technology & Human Resources", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl N. Kraus M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Charles Arnold", "title": "VP of Finance, Controller & Assistant Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 5, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.87, "open": 2.76, "dayLow": 2.615, "dayHigh": 2.825, "regularMarketPreviousClose": 2.87, "regularMarketOpen": 2.76, "regularMarketDayLow": 2.615, "regularMarketDayHigh": 2.825, "payoutRatio": 0.0, "beta": 2.591, "forwardPE": -4.5166664, "volume": 1298715, "regularMarketVolume": 1272343, "averageVolume": 1658448, "averageVolume10days": 1201550, "averageDailyVolume10Day": 1201550, "bid": 2.68, "ask": 2.74, "bidSize": 13, "askSize": 5, "marketCap": 267941504, "fiftyTwoWeekLow": 2.24, "fiftyTwoWeekHigh": 5.8, "priceToSalesTrailing12Months": 4.654914, "fiftyDayAverage": 2.9611, "twoHundredDayAverage": 3.7868, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 234399408, "profitMargins": -0.76679003, "floatShares": 94253087, "sharesOutstanding": 98871400, "sharesShort": 10228131, "sharesShortPriorMonth": 9977136, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1034, "heldPercentInsiders": 0.05045, "heldPercentInstitutions": 0.48349997, "shortRatio": 6.77, "shortPercentOfFloat": 0.122, "impliedSharesOutstanding": 98871400, "bookValue": -0.658, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -44137000, "trailingEps": -0.51, "forwardEps": -0.6, "enterpriseToRevenue": 4.072, "enterpriseToEbitda": -7.806, "52WeekChange": -0.33415234, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 2.71, "targetHighPrice": 15.0, "targetLowPrice": 4.75, "targetMeanPrice": 9.86111, "targetMedianPrice": 9.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 71546000, "totalCashPerShare": 0.724, "ebitda": -30030000, "totalDebt": 38004000, "quickRatio": 4.182, "currentRatio": 4.676, "totalRevenue": 57561000, "revenuePerShare": 0.664, "returnOnAssets": -0.24215001, "grossProfits": 39689000, "freeCashflow": -10494500, "operatingCashflow": -35759000, "revenueGrowth": -0.101, "grossMargins": 0.68951, "ebitdaMargins": -0.52171004, "operatingMargins": -1.1442701, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Aquestive Therapeutics, Inc.", "postMarketTime": 1743809395, "regularMarketTime": 1743796803, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.574908, "regularMarketPrice": 2.71, "shortName": "Aquestive Therapeutics, Inc.", "corporateActions": [], "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "postMarketChangePercent": -2.95203, "postMarketPrice": 2.63, "postMarketChange": -0.0799999, "regularMarketChange": -0.15999985, "regularMarketDayRange": "2.615 - 2.825", "fullExchangeName": "NasdaqGM", "marketState": "CLOSED", "averageDailyVolume3Month": 1658448, "fiftyTwoWeekLowChange": 0.47000003, "fiftyTwoWeekLowChangePercent": 0.20982145, "fiftyTwoWeekRange": "2.24 - 5.8", "fiftyTwoWeekHighChange": -3.0900002, "fiftyTwoWeekHighChangePercent": -0.53275865, "fiftyTwoWeekChangePercent": -33.415234, "earningsTimestamp": 1741208460, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "earningsCallTimestampStart": 1741266000, "earningsCallTimestampEnd": 1741266000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.51, "epsForward": -0.6, "epsCurrentYear": -0.64, "priceEpsCurrentYear": -4.234375, "fiftyDayAverageChange": -0.25110006, "fiftyDayAverageChangePercent": -0.08479959, "twoHundredDayAverageChange": -1.0767999, "twoHundredDayAverageChangePercent": -0.28435615, "priceToBook": -4.1185412, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]